MedEnrich | Página principal
Continue Watching
últimos vidéos
últimos vidéos
Brightcove Home Latest Listing
Cáncer de mama
Cáncer de mama
Brightcove Cards Listing
Cáncer de próstata
Brightcove Cards Listing
Mieloma múltiple
Mieloma múltiple
Brightcove Cards Listing
Popular en MedEnrich
Popular in Sin nombre
Mieloma múltiple11m 40s
How I Treat Relapsed Refractory Multiple Myeloma
Treating relapsed or refractory multiple myeloma (RRMM) can be complex and typically involves a combination of therapies based on the patient's previous treatments, overall health, and specific disease characteristics.
1
How I Treat Relapsed Refractory Multiple Myeloma
Oncology5m 37s
Intercambio Biosimilares: Una práctica segura
En este video, la Dra. Rosa Helena Bustos, la cual hace parte del departamento de Farmacología en la Universidad de la Sabana, nos invita a reflexionar de manera crítica sobre la importancia del uso de Biosimilares y como esto es una práctica segur.
1
Intercambio Biosimilares: Una práctica segura
Cáncer de mama14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
1
ESMO 2022 Breast Cancer Comprehensive Coverage
Myelodysplastic Syndromes8m 45s
Current Challenges in MDS Diagnosis and Consequences
Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
1
Current Challenges in MDS Diagnosis and Consequences
Oncology11m 30s
Biosimilares y sistemas de salud: Un examen crítico del acceso
En este video, el Dr. Julio García, médico QF de la Universidad de la Sabana, nos invita a reflexionar de manera crítica sobre la importancia del uso de Biosimilares y el acceso de estos en el sistema de salud.
1
Biosimilares y sistemas de salud: Un examen crítico...
Myelodysplastic Syndromes3m 18s
Anemia of MDS
Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
1
Anemia of MDS
Mieloma múltiple10m 19s
CAR -T cells in Lymphoma
CAR-T cell therapies are approved for treatment of Diffuse Large B Cell Lymphoma (DLBCL) , Follicular Lymphoma & Mantle Cell Lymphoma.
1
CAR -T cells in Lymphoma
Oncology3m 36s
Tissue Agnostic Treatment options in Solid Tumors
Tissue-agnostic treatment based on shared genetic aberrations have provided a new direction in cancer treatment. Emerging clinical evidence indicates that many molecular aberrations can be common across tumor types with different site of origin.
1
Tissue Agnostic Treatment options in Solid Tumors
Myelodysplastic Syndromes17m 59s
Genomics of AML -Therapeutic and Prognostic Implications
~40% of AML patients have targetable mutations. Younger patients often have FLT3-ITD or FLT3- TKD mutation. Mutations IDH-1 , IDH-2 & t-53 mutations are more common in elderly patients.
1
Genomics of AML -Therapeutic and Prognostic...
Mieloma múltiple3m 11s
Tips on using Pomalidomide Based Regimens in Multiple Myeloma
For relapsed and refractory multiple myeloma, use of pomalidomide often in combination with dexamethasone or other agents is recommended in patients who have failed at least two prior treatments, including lenalidomide and a proteasome inhibitor.
1
Tips on using Pomalidomide Based Regimens in...
Seminarios web anteriores
Seminarios web anteriores
Webinar Cards Listing
Artículos
Artículos
Medbytes Cards Listing
